Hims & Hers Health Inc (HIMS) Stock Price, Quote & News

Company Profile

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health a...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 415 851 0195

Website: www.hims.com

Address:

2269 Chestnut Street, Suite 523, San Francisco, United States

Kilocharlie Mar. 15 at 10:27 AM

$HIMS Allright finished my DD, been looking at this for a while. Me and my wife will take a first position tomorrow, each for 5400K ( 5000€).

0 · Reply

nnarum Mar. 15 at 10:22 AM

$HIMS

0 · Reply

MarketMaestro1 Mar. 15 at 9:27 AM

The setup for Hims & Hers Health ($HIMS) presents a classic tug-of-war between hyper-growth fundamentals and macro/regulatory fears. The Growth Engine: Revenue scaling from $270M (2021) to $2B+ (2026) is nothing short of spectacular. With projections maintaining an "up and to the right" trajectory, the fundamental disconnect with the recent price pullback is widening. The "Weight Loss" Factor: A significant driver of the recent surge has been their GLP-1 compounded offering. However, this is also the source of the regulatory risk you’re watching. Any shift in FDA stance on compounding once the "shortage" status of name-brand drugs ($LLY, $NVO) ends could impact margins. Execution is Key: Management has proven they can scale horizontally (Hair, Skin, Sex, Weight). If they maintain operational excellence and successfully navigate the regulatory maze, the current pullback might be remembered as a generational buying opportunity.

0 · Reply

Hbadwal21 Mar. 15 at 6:30 AM

$HIMS I am looking forward to the action next week. Does chatgpt really know something? Find out on the next episode of HIMS. $CVNA Did it and $GME did it!

0 · Reply

thelasthope Mar. 15 at 5:47 AM

$HIMS We should win this week due to quarterly rebalancing.

0 · Reply

HoodCutta Mar. 15 at 4:47 AM

Huge cup and handle on the 4 H $HIMS not sure how much volume we will get but if we can break resistance this week and push to 28+ we are in the money and have a good chance at a fight to 50 by EOY $HIMS

1 · Reply

Kuradick Mar. 15 at 4:41 AM

$HIMS

1 · Reply

domon Mar. 15 at 4:30 AM

$HIMS they use cheapest skimpies to advertise for their products. Is it because they cheaper 🤔..unbelievable!

0 · Reply

BullishRaidTrendTracker Mar. 15 at 3:21 AM

$HIMS Not surprised to see hims and hers doing well to the upside after the recent drop. Love the volume. https://www.youtube.com/watch?v=EBjbNfKaxfQ&t=7s

0 · Reply

IFOMODailyV2 Mar. 15 at 3:12 AM

$HIMS call options bought for this week :)

0 · Reply

OWL, HIMS, TSLA And More: 5 Stocks Investors Couldn't Stop Buzzing About This Week

TSLA OWL

Mar 12, 2026, 8:35 PM EDT - 2 days ago

Royce Smaller-Companies Growth Fund FY 2025: What Worked

ACVA ALVO AVAV FROG FRPT NVO PAR

Mar 12, 2026, 10:25 AM EDT - 2 days ago

Hims & Hers Health And Novo Nordisk: A Corporate Remarriage That May Work Out Profitably

NVO

Mar 11, 2026, 12:15 PM EDT - 3 days ago

Hims & Hers: The Novo Nordisk Deal Changes Everything

Mar 11, 2026, 10:40 AM EDT - 3 days ago

This Novo Nordisk Partnership Shows That HIMS Has All The Leverage

NVO

Mar 10, 2026, 8:08 PM EDT - 4 days ago

Hims & Hers Names Kathryn Beiser as Chief Communications Officer

Mar 10, 2026, 4:43 PM EDT - 4 days ago

Hims & Hers Health: The GLP-1 Chaos Is Fading, The Thesis Is Still On Track

Mar 10, 2026, 9:00 AM EDT - 4 days ago

Introducing Hims & Hers Benefits, Unlocking Health & Wellness Discounts for Subscribers

Mar 9, 2026, 5:51 PM EDT - 5 days ago

Hims & Hers: Not Selling Yet

Mar 9, 2026, 4:35 PM EDT - 5 days ago

Hims & Hers Health: The Juice Is Worth The Squeeze

Mar 9, 2026, 3:23 PM EDT - 5 days ago

Stock Of The Day: Will Hims & Hers Go Into Another Short Squeeze?

Mar 9, 2026, 1:27 PM EDT - 5 days ago

Hims & Hers stock: why today's gains are unlikely to be sustainable

Mar 9, 2026, 12:46 PM EDT - 5 days ago

Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc. - HIMS

Mar 9, 2026, 11:27 AM EDT - 5 days ago

Hims & Hers stock price is surging today. A surprising deal with Novo Nordisk is the reason why

NVO

Mar 9, 2026, 11:00 AM EDT - 5 days ago

HIMS Skyrockets on Reported Deal with NVO to Sell GLP-1s

NVO

Mar 9, 2026, 10:38 AM EDT - 5 days ago

Novo Nordisk drops Him & Hers lawsuit

NVO

Mar 9, 2026, 10:32 AM EDT - 5 days ago

Hims & Hers Stock Pops on a Deal With Rival Novo Nordisk—What You Need to Know

Mar 9, 2026, 9:23 AM EDT - 5 days ago

Hims stock jumps 50% as Novo Nordisk ends lawsuit, strikes deal

Mar 9, 2026, 8:52 AM EDT - 5 days ago

Hims & Hers shares surge 50% after Novo Nordisk ends legal feud over compounded weight loss drugs

NVO

Mar 9, 2026, 8:35 AM EDT - 5 days ago

What's Happening With HIMS Stock?

Mar 9, 2026, 8:33 AM EDT - 5 days ago

Novo Nordisk strikes deal for Hims to sell Wegovy and Ozempic, drops lawsuit

NVO

Mar 9, 2026, 8:30 AM EDT - 5 days ago

Hims & Hers Announces Strategic Shift for US Weight Loss Business

Mar 9, 2026, 7:04 AM EDT - 6 days ago

Hims & Hers, Novo Nordisk Weight-Loss Drug Deal Ends Legal Feud, Stock Soars

NVO

Mar 9, 2026, 6:33 AM EDT - 6 days ago

Hims shares jump after report of Novo Nordisk partnership that may end legal feud

NVO

Mar 9, 2026, 6:33 AM EDT - 6 days ago

Hims & Hers Stock Soars 54%. It's Struck a Truce With Novo Nordisk, Report Says.

NVO

Mar 9, 2026, 6:06 AM EDT - 6 days ago

Hims & Hers Shares Double on Report of Wegovy Tie-Up

Mar 9, 2026, 5:45 AM EDT - 6 days ago

Hims & Hers stock rockets on reported end to Novo Nordisk weight-loss drug dispute

NVO

Mar 6, 2026, 8:04 PM EST - 8 days ago

Novo and Hims resolve dispute, will sell obesity drugs together, Bloomberg News reports

NVO

Mar 5, 2026, 3:19 PM EST - 9 days ago

YieldMax® HIMS Option Income Strategy ETF (HIYY) Trading Halt

Mar 3, 2026, 10:57 AM EST - 11 days ago

Hims & Hers Health: Leaving GLP-1s Behind

Mar 3, 2026, 10:40 AM EST - 11 days ago

Hims' pharmacy partner will reintroduce GLP-1 pill pulled from market, Endpoints News reports

Mar 2, 2026, 8:17 PM EST - 12 days ago

Hims & Hers Health, Inc. (HIMS) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript

Mar 2, 2026, 2:28 PM EST - 12 days ago

Carillon Eagle Small Cap Growth Fund Q4 2025 Portfolio Review

BE BTSG COHR ESTA GH ITRI PRKS

Mar 2, 2026, 12:00 PM EST - 12 days ago

Glancy Prongay Wolke & Rotter LLP Announces Investigation of Hims & Hers Health, Inc. (HIMS) on Behalf of Investors

Mar 2, 2026, 9:16 AM EST - 12 days ago

Hims expansion may not come in time for risky GLP-1 business

Mar 1, 2026, 4:00 PM EST - 13 days ago

HIMS Core Business Faces Challenges in Guidance, GLP-1 Prices & NVO

Feb 27, 2026, 12:00 PM EST - 15 days ago

Law Offices of Howard G. Smith Announces Investigation of Hims & Hers Health, Inc. (HIMS) on Behalf of Investors

Feb 25, 2026, 7:18 PM EST - 17 days ago

The Law Offices of Frank R. Cruz Announces Investigation of Hims & Hers Health, Inc. (HIMS) on Behalf of Investors

Feb 25, 2026, 11:07 AM EST - 17 days ago

Hims & Hers Health: The GLP-1 Party Is Over

Feb 24, 2026, 4:02 PM EST - 18 days ago

Hims & Hers Health: Don't Get Lost In The Weeds

Feb 24, 2026, 2:30 PM EST - 18 days ago

Hims & Hers Health: Great Vision, Now On Sale -- Here's Why I'm Upgrading

Feb 24, 2026, 12:46 PM EST - 18 days ago

Hims & Hers Health Analysts Cut Their Forecasts After Q4 Results

Feb 24, 2026, 10:30 AM EST - 18 days ago

KDP Beats & HIMS Misses Sales, QCOM Gains on Upgrades

QCOM KDP

Feb 24, 2026, 8:47 AM EST - 18 days ago

Hims & Hers Health After The GLP-1 Collapse

Feb 24, 2026, 8:32 AM EST - 18 days ago

Hims & Hers Stock Stumbles - Cautions About Pressure Due To Super Bowl Ad, Change In Shipping Cadences

Feb 24, 2026, 6:40 AM EST - 18 days ago

Wall Street Breakfast Podcast: FedEx Demands Tariffs Return To Sender

COST FDX IBM

Feb 24, 2026, 6:30 AM EST - 19 days ago

Hims & Hers Q4 Earnings Show Growth Amid GLP-1 Scrutiny

Feb 23, 2026, 9:25 PM EST - 19 days ago

Hims & Hers Health, Inc. (HIMS) Q4 2025 Earnings Call Transcript

Feb 23, 2026, 7:44 PM EST - 19 days ago

Hims & Hers' expansion plans — as well as its Super Bowl ad — have investors worried about profits

Feb 23, 2026, 4:31 PM EST - 19 days ago

Hims & Hers Health Fourth-Quarter Profit Falls Despite Higher Revenue

Kilocharlie Mar. 15 at 10:27 AM

$HIMS Allright finished my DD, been looking at this for a while. Me and my wife will take a first position tomorrow, each for 5400K ( 5000€).

0 · Reply

nnarum Mar. 15 at 10:22 AM

$HIMS

0 · Reply

MarketMaestro1 Mar. 15 at 9:27 AM

0 · Reply

Hbadwal21 Mar. 15 at 6:30 AM

$HIMS I am looking forward to the action next week. Does chatgpt really know something? Find out on the next episode of HIMS. $CVNA Did it and $GME did it!

0 · Reply

thelasthope Mar. 15 at 5:47 AM

$HIMS We should win this week due to quarterly rebalancing.

0 · Reply

HoodCutta Mar. 15 at 4:47 AM

1 · Reply

Kuradick Mar. 15 at 4:41 AM

$HIMS

1 · Reply

domon Mar. 15 at 4:30 AM

$HIMS they use cheapest skimpies to advertise for their products. Is it because they cheaper 🤔..unbelievable!

0 · Reply

BullishRaidTrendTracker Mar. 15 at 3:21 AM

$HIMS Not surprised to see hims and hers doing well to the upside after the recent drop. Love the volume. https://www.youtube.com/watch?v=EBjbNfKaxfQ&t=7s

0 · Reply

IFOMODailyV2 Mar. 15 at 3:12 AM

$HIMS call options bought for this week :)

0 · Reply

lunchtrader0404 Mar. 15 at 3:01 AM

$HIMS desperately looking for a news to get hyped about this stock this is a month old news smh

0 · Reply

EvBullforever13 Mar. 15 at 2:34 AM

$OSCR great read…it’s a must own… $CNC $HIMS $UNH $ELVR https://tradepal.co/blog/why-oscar-health-could-be-one-of-most

0 · Reply

andreasnewitsch Mar. 15 at 1:27 AM

$HIMS stock twits says extremely bullish

0 · Reply

Joby099 Mar. 15 at 12:56 AM

$HIMS

0 · Reply

WallStreetBuyDip Mar. 15 at 12:21 AM

$TDOC sitting at $5 with volume 38% below average, while $HIMS trading at $25 with volume 24% above average. HIMS showing strength compared to TDOC in the Healthcare sector. Will sector trends continue to favor higher-priced stocks like HIMS?

0 · Reply

CasperPuff Mar. 14 at 11:47 PM

$HIMS https://www.investors.com/news/technology/hims-stock-acquisition-eucaplyptus-weight-loss?mod=msn_ibd_fullbd

1 · Reply

OptionsLover69 Mar. 14 at 11:46 PM

$HIMS imagine being a bear and afraid of losing your $500 worth of puts so you post FUD all weekend instead of going outside @SnackMe

1 · Reply

CashMoneyGreen Mar. 14 at 11:38 PM

$HIMS rip to 60

0 · Reply

qdf Mar. 14 at 11:10 PM

$HIMX Hunterbrook Capital, the investment arm of Hunterbrook Media, trades based on investigative reporting by its newsroom. As of March 2026, the firm’s disclosed positions include: Recent Long Positions Himax Technologies ($HIMX): Hunterbrook is long as of March 12, 2026, reporting that the company is a "stealth supplier" for Nvidia and Apple. Hims & Hers Health ($HIMS): Shifted to a long position in late 2024, citing the potential for stabilized regulatory conditions under new leadership. Rocket Companies ($RKT): A core long holding established during the firm's initial investigation into United Wholesale Mortgage. Other Noted Holdings: Recent reports have also listed Core Scientific, Evolv Technologies, and Carpenter Technology as portfolio names.

1 · Reply

andreasnewitsch Mar. 14 at 10:33 PM

$HIMS i know i sounds like a broken record but you tubers are very positive about hims.

0 · Reply

SnackMe Mar. 14 at 10:27 PM

$HIMS unfortunate truth , ur competition🔥

3 · Reply

55TT_S Mar. 14 at 9:50 PM

$HIMS the link to this was posted so sure you saw it. This guy was a big short and clearly his sentiment has changed.

0 · Reply

Market Cap	5.65B
Revenue (ttm)	2.35B
Net Income (ttm)	128.37M
EPS (ttm)	N/A
PE Ratio	49.54
Forward PE	45.33
Profit Margin	5.47%
Debt to Equity Ratio	0.00

Volume	42,982,400
Avg Vol	35,197,129
Day's Range	N/A - N/A
Shares Out	227.94M
Stochastic %K	78%
Beta	2.55
Analysts	Sell
Price Target	$24.42